Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,087
Closed -$1.67M 67
2023
Q3
$1.67M Buy
+24,087
New +$1.82M 0.32% 63
2018
Q3
Sell
-87,500
Closed -$3.48M 121
2018
Q2
$3.48M Buy
+87,500
New +$3.37M 1.39% 19
2018
Q1
Sell
-90,000
Closed -$3.85M 81
2017
Q4
$3.85M Buy
+90,000
New +$3.59M 1.61% 25
2017
Q2
Sell
-252,500
Closed -$10.7M 79
2017
Q1
$10.7M Buy
252,500
+38,075
+18% +$1.55M 3.18% 2
2016
Q4
$8.6M Buy
+214,425
New +$8.27M 3.15% 7

Other funds holding HOLX

Pura Vida Investments's HOLX Position: Q4 2023 in Review

Pura Vida Investments sold out of Hologic (HOLX) in Q4 2023, closing a stake of 24,087 shares — an estimated $1.67M sold.

Pura Vida Investments first reported a position in HOLX in Q4 2016 and held it in 5 quarters. The position peaked at $10.7M in Q1 2017. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Pura Vida Investments reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Pura Vida Investments sold 24,087 Hologic shares in Q4 2023, an estimated $1.67M.
  • Pura Vida Investments first reported a position in Hologic in Q4 2016 and held it in 5 quarters.
  • Pura Vida Investments's Hologic position peaked at $10.7M in Q1 2017.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Pura Vida Investments's 13F filing for Q4 2023, filed 13 Feb 2024.